Concepedia

William L. Trepicchio

WL

43

Publications

4.5K

Citations

29

H-Index

1985

Active since

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Dana-Farber Cancer Institute

Harvard University

The University of Texas MD Anderson Cancer Center

William L. Trepicchio is an author at Millennium Engineering and Integration (United States) specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

1985–2022

43

Publications

43

Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

Edmund Lee, William L. Trepicchio, Judith Oestreicher et al. · The Journal of Experimental Medicine · 2004 · 889 citations · Full text

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

, , +9

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant et al. · Blood · 2006 · 409 citations · Full text

Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production

William L. Trepicchio, M Bozza, G Pedneault et al. · The Journal of Immunology · 1996 · 288 citations

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions

William L. Trepicchio, Maki Ozawa, Ian Walters et al. · Journal of Clinical Investigation · 1999 · 222 citations · Full text

Rows per page

1–5 of 43